US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist
  • 0.5299
  • +0.0258+5.12%
Close Dec 20 16:00 ET
  • 0.5100
  • -0.0199-3.76%
Post 19:59 ET
2.59MMarket Cap-0.01P/E (TTM)

NovaBay Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NovaBay Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.000M--
--2024/Q4-- / 2.500M--
--2024/Q32.441M / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.000M--
--2024/Q4-- / 2.500M--
--2024/Q32.441M / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--

Unlock Free Earnings Estimates

NovaBay Pharmaceuticals Earnings Reports

  • NovaBay Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:20 ET

  • NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:15 ET

  • NovaBay Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:22 ET

  • NovaBay Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Mar 29 11:02 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data